© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Plugging the Gap or Opening the Floodgates?
Innovation
09/04/2018Plugging the Gap or Opening the Floodgates?

David Skelton, Partner in Construction & Engineering at Womble Bond Dickinson provides his opinion on the two recent decisions of the Technology and Construction Court.

Read Full PostRead - Eye Icon
Mobile Operators Sitting on ‘Treasure Trove of Rich Information’ with Movement Analytics
Innovation
Read Full PostRead - Eye Icon
How to Choose the Best Software Development Company in 2023
Innovation
24/07/2023How to Choose the Best Software Development Company in 2023

Choosing the ideal partner might seem like a difficult process with so many businesses providing their services. However, you may make an informed choice that supports your company's objectives by taking certain criteria into account and using a methodical app

Read Full PostRead - Eye Icon
7 Ways Hiring a Lawyer for a Wrongful Death Case Can Be Beneficial
Legal
24/05/20237 Ways Hiring a Lawyer for a Wrongful Death Case Can Be Beneficial

Losing a loved one is depressing. It’s even more devastating when someone’s negligence or malicious intent causes their death. The Port of Milwaukee is important for global trade, but it increases truck traffic, which increases the risk of fatal motor vehi

Read Full PostRead - Eye Icon
Creating Innovative Technologies in the Cardiovascular Space
Leadership
16/01/2018Creating Innovative Technologies in the Cardiovascular Space

FineHeart is a French medical device company focused on creating innovative technologies in the cardiovascular space.

Read Full PostRead - Eye Icon
Proud to Support its Veterans
News
05/10/2022Proud to Support its Veterans

Woodside Quality LLC (Woodside) is a CVE Certified Service-Disabled Veteran Owned Small Business (SDVOSB) providing performance improvement, project management, and analytics support to federal and commercial clients.

Read Full PostRead - Eye Icon
Changing of the Guard
Leadership
02/12/2019Changing of the Guard

Changing of the Guard The London Internet Exchange (LINX) was established in 1994, using a donated piece of equipment no larger than a set-top box, no legal contracts and five founding members wanting to keep traffic local and avoid transatlantic fees. Now spr

Read Full PostRead - Eye Icon
Jack Of All Trades
Innovation
30/04/2021Jack Of All Trades

Jacksoft Commerce Automation is a pioneering firm of Regtech and Computer Auditing Experts situated in Taipei, Taiwan. Specialists in IT and auditing services for businesses of all shapes and sizes, Jacksoft provides market-leading automated solutions and worl

Read Full PostRead - Eye Icon
Revolutionizing Business: How Innovative IT Infrastructure Drives Growth Introduction
News
21/09/2023Revolutionizing Business: How Innovative IT Infrastructure Drives Growth Introduction

In a digital and technologically advanced paradigm, focusing on a single aspect is not going to expand business. Each part of an enterprise operates smoothly with a proper IT infrastructure in position. It has a crucial significance for business growth and eff



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow